Healthcare provider profile · identity verified

Deborah Ann Smith, MD

Family Practice · JIM THORPE, PA · NPI 1154382604

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	498	111
Atorvastatin Calcium	Atorvastatin Calcium	356	84
Lisinopril	Lisinopril	344	88
Amlodipine Besylate	Amlodipine Besylate	261	64
Alprazolam	Alprazolam	208	44
Metoprolol Tartrate	Metoprolol Tartrate	207	43
Rosuvastatin Calcium	Rosuvastatin Calcium	201	49
Lorazepam	Lorazepam	198	46
Simvastatin	Simvastatin	191	44
Metformin Hcl	Metformin Hcl	185	42
Omeprazole	Omeprazole	178	48
Metoprolol Succinate	Metoprolol Succinate	167	39
Gabapentin	Gabapentin	147	24
Pantoprazole Sodium	Pantoprazole Sodium	126	39
Famotidine	Famotidine	120	29
Furosemide	Furosemide	113	39
Montelukast Sodium	Montelukast Sodium	113	25
Potassium Chloride	Potassium Chloride	110	23
Eliquis	Apixaban	108	23
Zolpidem Tartrate	Zolpidem Tartrate	101	24
Irbesartan	Irbesartan	94	17
Clopidogrel	Clopidogrel Bisulfate	92	22
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	91	14
Hydrochlorothiazide	Hydrochlorothiazide	88	25
Clonidine Hcl	Clonidine Hcl	80	14
Ozempic	Semaglutide	78	16
Tramadol Hcl	Tramadol Hcl	78	19
Fluoxetine Hcl	Fluoxetine Hcl	76	18
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	74	13
Atenolol	Atenolol	73	22
Fluticasone Propionate	Fluticasone Propionate	67	18
Citalopram Hbr	Citalopram Hydrobromide	66	15
Jardiance	Empagliflozin	66	15
Tamsulosin Hcl	Tamsulosin Hcl	66	17
Losartan Potassium	Losartan Potassium	65	14
Meloxicam	Meloxicam	64	22
Tizanidine Hcl	Tizanidine Hcl	60	12
Oxycodone Hcl	Oxycodone Hcl	58	11
Albuterol Sulfate Hfa	Albuterol Sulfate	55	24
Metformin Hcl Er	Metformin Hcl	55	15
Synthroid	Levothyroxine Sodium	55	16
Bumetanide	Bumetanide	54	suppressed
Allopurinol	Allopurinol	52	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	51	11
Trazodone Hcl	Trazodone Hcl	51	11
Cephalexin	Cephalexin	48	32
Duloxetine Hcl	Duloxetine Hcl	48	suppressed
Prednisone	Prednisone	48	30
Sertraline Hcl	Sertraline Hcl	47	14
Warfarin Sodium	Warfarin Sodium	46	suppressed
Farxiga	Dapagliflozin Propanediol	45	suppressed
Carvedilol	Carvedilol	43	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	42	suppressed
Clonazepam	Clonazepam	38	suppressed
Alendronate Sodium	Alendronate Sodium	36	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	36	22
Oxybutynin Chloride Er	Oxybutynin Chloride	36	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	35	suppressed
Methocarbamol	Methocarbamol	35	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	35	suppressed
Valsartan	Valsartan	34	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	33	suppressed
Glipizide	Glipizide	32	suppressed
Baclofen	Baclofen	31	suppressed
Lansoprazole	Lansoprazole	31	suppressed
Xarelto	Rivaroxaban	31	suppressed
Torsemide	Torsemide	30	suppressed
Ezetimibe	Ezetimibe	28	suppressed
Celecoxib	Celecoxib	27	suppressed
Donepezil Hcl	Donepezil Hcl	27	suppressed
Sucralfate	Sucralfate	26	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	26	suppressed
Amoxicillin	Amoxicillin	25	13
Quetiapine Fumarate	Quetiapine Fumarate	25	suppressed
Breo Ellipta	Fluticasone/Vilanterol	24	suppressed
Buspirone Hcl	Buspirone Hcl	24	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	24	suppressed
Finasteride	Finasteride	24	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	24	suppressed
Nifedipine Er	Nifedipine	24	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	23	suppressed
Mirtazapine	Mirtazapine	23	suppressed
Pravastatin Sodium	Pravastatin Sodium	23	suppressed
Temazepam	Temazepam	23	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	23	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	22	suppressed
Januvia	Sitagliptin Phosphate	22	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	21	19
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	21	suppressed
Levetiracetam	Levetiracetam	21	suppressed
Pregabalin	Pregabalin	21	suppressed
Tradjenta	Linagliptin	21	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	21	suppressed
Calcitriol	Calcitriol	20	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	20	suppressed
Azelastine Hcl	Azelastine Hcl	19	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	19	suppressed
Ondansetron Odt	Ondansetron	19	14
Oxycontin	Oxycodone Hcl	19	suppressed
Trulicity	Dulaglutide	19	suppressed
Bupropion Xl	Bupropion Hcl	18	suppressed
Rizatriptan	Rizatriptan Benzoate	18	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	18	11
Divalproex Sodium	Divalproex Sodium	17	suppressed
Klor-Con M20	Potassium Chloride	17	suppressed
Ropinirole Hcl	Ropinirole Hcl	17	suppressed
Rybelsus	Semaglutide	17	suppressed
Spironolactone	Spironolactone	17	suppressed
Carbamazepine	Carbamazepine	16	suppressed
Methotrexate	Methotrexate Sodium	16	suppressed
Myrbetriq	Mirabegron	16	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	16	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	16	suppressed
Fenofibrate	Fenofibrate	15	suppressed
Galantamine Er	Galantamine Hbr	15	suppressed
Methenamine Hippurate	Methenamine Hippurate	15	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	15	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	14	suppressed
Digoxin	Digoxin	14	suppressed
Meclizine Hcl	Meclizine Hcl	14	suppressed
Morphine Sulfate Er	Morphine Sulfate	14	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	14	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	13	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	13	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	13	suppressed
Fentanyl	Fentanyl	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Verapamil Sr	Verapamil Hcl	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Phenobarbital	Phenobarbital	11	suppressed
Ventolin Hfa	Albuterol Sulfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error